SCHEMBL9753707

SCHEMBL9753707

Cc1cc(C)n2nc(C(C)C)c(C=CC=O)c(-c3ccc(F)cc3)c12

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GCGR P47871 6/20 0.36
PTGS2 P35354 3/20 0.35
HMGCR P04035 2/20 0.35
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.32
MAPK10 P53779 1/20 0.32
MAPK14 Q16539 1/20 0.32
ESR1 P03372 1/20 0.32
CHRM1 P11229 1/20 0.32
TBXA2R P21731 1/20 0.32
PDE4A P27815 1/20 0.32
ADRA1A P35348 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9753703 1.00 GCGR (0.36) GCGRPTGS2HMGCRNPC1RAB9A
SCHEMBL9753207 0.90 ALDH1A1 (0.40) GCGRPTGS2HMGCRNPC1RAB9A
SCHEMBL9752949 0.83 MAPK14 (0.40) GCGRPTGS2HMGCRALDH1A1MAPK10
SCHEMBL9752948 0.83 MAPK14 (0.40) GCGRPTGS2HMGCRALDH1A1MAPK10
SCHEMBL9753671 0.81 PTGS2 (0.37) PTGS2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9753676 0.81 PTGS2 (0.37) PTGS2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9752968 0.78 MAPK14 (0.39) GCGRPTGS2HMGCRMAPK10MAPK14
SCHEMBL9752967 0.78 MAPK14 (0.39) GCGRPTGS2HMGCRMAPK10MAPK14
SCHEMBL27346853 0.77 PPARA (0.41) GCGRPTGS2HMGCRNPC1RAB9A
SCHEMBL9753373 0.77 HMGCR (0.60) PTGS2HMGCRALDH1A1ESR1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991018903-A1 PYRROLOPYRIDAZINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-12 WO disclosed
CN-1056690-A PYRROLOPYRIDAZINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO (JP) 1991-12-04 CN disclosed